← Back to Search

Cognitive Support Technology for Autism

N/A
Recruiting
Research Sponsored by Kent State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must have a clinical diagnosis of Autism Spectrum Disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (enrollment in study), 6 months, and 1 year (study completion)
Awards & highlights

Study Summary

This trial will help fill important gaps in knowledge about how to best help people with ASD transition from postsecondary education to employment.

Who is the study for?
This trial is for post-secondary students within a 60-mile radius of Kent, Ohio who have been clinically diagnosed with Autism Spectrum Disorder (ASD). It's designed to help these students transition from education to employment.Check my eligibility
What is being tested?
The study tests Cognitive Support Technology (CST) that combines assistive technology and vocational rehabilitation practices. The goal is to improve academic success and career readiness for students with ASD.See study design
What are the potential side effects?
Since the intervention involves educational support technology, risks are minimal and similar to everyday life. There may be no direct medical side effects, but support will be provided if psychological distress arises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Autism Spectrum Disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (enrollment in study), 6 months, and 1 year (study completion)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (enrollment in study), 6 months, and 1 year (study completion) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Grade Point Average (GPA)
Secondary outcome measures
% of Participants Receiving Disability Benefits
Acceptance of Disability
Current Employment Status
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Full TreatmentExperimental Treatment1 Intervention
Steps of the Intervention Condition. Following an in-person session in which a pretest assessment is completed, each member of the intervention group will participate in three face-to-face sessions with the interventionist at the student's campus or at the interventionist's office to complete the CST component of the intervention. Taking into consideration available psychoeducational assessment data, functional assessments from other agencies, and the participant's self-report regarding the functional difficulties that result from his or her ASD-related cognitive impairments, Scherer's (2012) Matching Person and Technology (MPT) protocol will guide the CST assessment. For purposes of the CST component of this intervention, the technological platform for cognitive accommodations will be an iPad II that is provided to each intervention-group participant at no charge (including wireless access if needed). The interventionist will provide training in the use of the iPad if necessary.
Group II: Abbreviated TreatmentActive Control1 Intervention
Steps of the Control Condition. Following an in-person session in which the pretest assessment is completed, each member of the control group will participate in two telephone or Skype sessions with the interventionist to discuss her or his needs for electronic cognitive supports. An abbreviated version of Scherer's (2012) MPT assessment will be administered via telephone or Skype in the first of these virtually-administered sessions. In the second telephone or Skype session, the interventionist will summarize the results of the abbreviated MPT assessment, suggest a variety of cognitive enhancement apps for tablet computers or smart phones that the control group participant can consider.

Find a Location

Who is running the clinical trial?

Kent State UniversityLead Sponsor
41 Previous Clinical Trials
6,503 Total Patients Enrolled
Virginia Commonwealth UniversityOTHER
699 Previous Clinical Trials
22,884,955 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
259 Patients Enrolled for Autism Spectrum Disorder

Media Library

Cognitive Support Technology (CST) Clinical Trial Eligibility Overview. Trial Name: NCT04980963 — N/A
Autism Spectrum Disorder Research Study Groups: Full Treatment, Abbreviated Treatment
Autism Spectrum Disorder Clinical Trial 2023: Cognitive Support Technology (CST) Highlights & Side Effects. Trial Name: NCT04980963 — N/A
Cognitive Support Technology (CST) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04980963 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers have enrolled in this medical trial thus far?

"Indeed, clinicaltrials.gov attests that this research initiative is currently recruiting participants. The trial was initially made available on March 1st 2020 and has been updated as recently as July 19th 2021. Ninety individuals are needed to join the study at a single location."

Answered by AI

Are there any openings for prospective participants in this research endeavor?

"Affirmative. The information hosted on clinicaltrials.gov demonstrates that this research project, first introduced on March 1st 2020, is currently recruiting participants. A total of 90 individuals will be accepted from one medical site."

Answered by AI

Who else is applying?

What state do they live in?
Florida
New York
Pennsylvania
How old are they?
< 18
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
What site did they apply to?
Kent State University
~4 spots leftby Jun 2024